论文信息 - First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery - 字舞流文

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

H. Thieme | N. Pfeiffer | M. Janicot | K. Lorenz | K. Wosikowski | P. Fettes | E. Leo | C. Mala | K. Bell | B. Voykov | G. Renieri | Paul Richter | M. Feindor | M. Weigel | B. Wilhelm | Daniela Päckert | R. Römmich